Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis
Status:
Terminated
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
This study is designed to confirm the safety of the proposed dose and schedule of ABI-007 for
hemodialysis patients with vascular access device failure, and to obtain preliminary data on
the effectiveness of such treatment.